Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Immune Cell Function and Interaction, and Immunotherapy and Immune Responses.
Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity
PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance
A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity
Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade
BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes